Intelligent Bio Solutions Inc.

The momentum for this stock is not very good. Intelligent Bio Solutions Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Intelligent Bio Solutions Inc. .

News

Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Virtual Conference on September 18-19, 2024

Globe Newswire NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a leader in non-invasive drug testing technology, today announced that its...\n more…

What's Going On With Opiate Screening Tests-Focused Intelligent Bio Solutions Stock On Monday?

Benzinga Intelligent Bio Solutions stock surges with increased trading volume, driven by progress on its FDA 510(k) submission. The company, specializing in non-invasive testing, advances clinical trials and reports significant growth in drug screening system installations.\n more…

Intelligent Bio Solutions stock rallies on reporting Q4 revenue of $0.73M, up 64% Y/Y

Seeking Alpha - Healthcare Intelligent Bio Solutions stock rallies on reporting Q4 revenue of $0.73M, up 64% Y/Y...\n more…

Intelligent Bio Solutions reports Q4 rvenue $0.73M, up 64% year-over-year

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Intelligent Bio Solutions Inc. Announces Preliminary Full Fiscal Year 2024 Revenue Growth of 148% Year-Over-Year

Globe Newswire - 2024 unaudited revenue growth for the fiscal fourth quarter and full year of approximately 64% and 148% year-over-year, respectively - NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Intelligent...\n more…

Intelligent Bio Solutions Advances in FDA Approval Process

TipRanks Financial Blog Intelligent Bio Solutions ( ($INBS) ) has issued an announcement. Intelligent Bio Solutions Inc. has announced significant progress in its clinical study plan, a cr...\n more…